WATERFORD, Va., Feb. 9 /PRNewswire-FirstCall/ -- American Med Tech, Inc. ( RBRM) Manufacturers of Neuropathy and Molluscum Contagiosum treatments today announced that sales for the first month of 2009 have exceeded December of 2008.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
"After re-organizing the company (RBRM) to relieve it of the risk of daily operations in exchange for full administrative support and royalties on sales, we were pleased to see that perhaps we are the harbingers of an economic turn around," said David Phillips, Ph.D. CEO.
Additionally, Dr. Phillips reports: "Traditionally health related companies have always fares better than companies selling consumer items that relay on disposable income. Because we have the only cure for a highly contagious skin disease, Molluscum Contagiosum that afflicts 15% of American children, and we have an effective means of regenerating nerves electrically, our customers have very real pain that cannot be put off into the future."
Finally, Dr. Phillips told reporters today: "We are traveling out of state next week to do due diligence on an exciting new business relationship that we will report details on later."
Inquiries can be made at www.americanmedtech.com. E mail inquiries can be sent to davidphillipsmail@yahoo.com. Phone is 304-725-2202.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.
SOURCE American Med Tech, Inc. (Formerly dba as ReBuilder Medical Technologies, Inc.)
URL: http://www.americanmedtech.com/
SOURCE American Med Tech, Inc.
